Tag: should-replace

By Ben Hirschler LONDON (Reuters) – New global guidelines on the treatment of heart failure strongly endorse the use of Novartis’ Entresto, boosting the prospects for a drug that has struggled to gain traction since its launch last year. U.S. and European heart experts gave the highest “class 1” recommendation to Entresto for use in…